Contact
Please use this form to send email to PR contact of this press release:
Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
TO:
Please use this form to send email to PR contact of this press release:
Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan
TO: